Currently Hilda is appointed as a senior researcher at OPRI where she is involved in many different research projects. Before Hilda started at OPRI, she applied, and was successfully granted with two postdoctoral fellowships in pharmacoepidemiology in multiple sclerosis at the University of British Columbia (UBC), Canada. This joint postdoctoral research program with Maastricht University Medical Centre (MUMC) and Nivel, the Netherlands, resulted in interesting studies with different health administrative databases. Hilda completed her PhD in pharmacoepidemiology at the MUMC, Utrecht University and RIVM, the Netherlands. Her PhD research focused on the association(s) between cardiovascular drugs and the risk of developing autoimmune diseases, using several health administrative databases. She completed her MSc in human nutrition from Wageningen University, the Netherlands. Her research interests include pharmacoepidemiology in chronic inflammatory diseases, effectivity, safety and tolerability of drugs, epidemiological methods, and the use of linked administrative health databases for population-based research.
Hilda de Jong, PhD